[DOI] [PubMed] [Google Scholar] 40.Theodorou A.S., Havenetidis K., Zanker C.L., OHara J.P., King R.F., Hood C., Paradisis G., Cooke C.B
Heres a closer look at trial findings: In an OASIS-4 clinical trial , people who took 25 mg of oral semaglutide daily lost an average of 13.6% of their body weight after 64 weeks (about a year and three months)
6.7 Effect onNAFLD (non-alcoholic fatty liver disease) outcomes The literature extensively outlines the connection between NAFLD and extra-hepatic manifestations that hold clinical significance.Younossi et al
And so I think it still remains the case that a multidisciplinary program thats evidence based will continue to deliver better and more sustained outcomes for patients with obesity and be an appropriate solution for patients with these types of conditions, just as having specialty care is appropriate for patients with cardiac conditions, pulmonary conditions, endocrine conditions
However, seek urgent medical attention if you develop severe abdominal pain, persistent vomiting preventing fluid intake, signs of pancreatitis (severe upper abdominal pain radiating to the back), gallbladder problems (severe right upper quadrant pain, fever, or jaundice), or signs of allergic reaction (rash, facial swelling, or breathing difficulties)
The gut barrier helps maintain separation between the intestinal environment and the rest of the body, supporting digestive health, immune balance, and overall gut function
